These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32676014)

  • 21. Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review.
    Aly E; Masocha W
    IBRO Neurosci Rep; 2021 Jun; 10():109-118. PubMed ID: 34179865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute effects of cannabinoids on addiction endophenotypes are moderated by genes encoding the CB1 receptor and FAAH enzyme.
    Hindocha C; Freeman TP; Schafer G; Gardner C; Bloomfield MAP; Bramon E; Morgan CJA; Curran HV
    Addict Biol; 2020 May; 25(3):e12762. PubMed ID: 31013550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotection Following Concussion: The Potential Role for Cannabidiol.
    Singh J; Neary JP
    Can J Neurol Sci; 2020 May; 47(3):289-300. PubMed ID: 32029015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeated Cannabidiol treatment reduces cocaine intake and modulates neural proliferation and CB1R expression in the mouse hippocampus.
    Luján MÁ; Castro-Zavala A; Alegre-Zurano L; Valverde O
    Neuropharmacology; 2018 Dec; 143():163-175. PubMed ID: 30273593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoids and the endocannabinoid system in reward processing and addiction: from mechanisms to interventions
.
    Spanagel R
    Dialogues Clin Neurosci; 2020 Sep; 22(3):241-250. PubMed ID: 33162767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
    Fernández-Ruiz J; Sagredo O; Pazos MR; García C; Pertwee R; Mechoulam R; Martínez-Orgado J
    Br J Clin Pharmacol; 2013 Feb; 75(2):323-33. PubMed ID: 22625422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible Receptor Mechanisms Underlying Cannabidiol Effects on Addictive-like Behaviors in Experimental Animals.
    Galaj E; Xi ZX
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol.
    Romano B; Borrelli F; Pagano E; Cascio MG; Pertwee RG; Izzo AA
    Phytomedicine; 2014 Apr; 21(5):631-9. PubMed ID: 24373545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A time-dependent contribution of hippocampal CB
    Raymundi AM; da Silva TR; Zampronio AR; Guimarães FS; Bertoglio LJ; Stern CAJ
    Br J Pharmacol; 2020 Feb; 177(4):945-957. PubMed ID: 31648363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabidiol or CBD Oil: Help, Hope, and Hype for Psychiatric and Neurologic Conditions.
    Newton M; Newton DW
    J Am Psychiatr Nurses Assoc; 2020; 26(5):447-457. PubMed ID: 32508204
    [No Abstract]   [Full Text] [Related]  

  • 31. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB
    Stern CAJ; da Silva TR; Raymundi AM; de Souza CP; Hiroaki-Sato VA; Kato L; Guimarães FS; Andreatini R; Takahashi RN; Bertoglio LJ
    Neuropharmacology; 2017 Oct; 125():220-230. PubMed ID: 28754373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid System.
    Schonhofen P; Bristot IJ; Crippa JA; Hallak JEC; Zuardi AW; Parsons RB; Klamt F
    CNS Drugs; 2018 Aug; 32(8):697-712. PubMed ID: 30109642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease.
    Crivelaro do Nascimento G; Ferrari DP; Guimaraes FS; Del Bel EA; Bortolanza M; Ferreira-Junior NC
    Neuropharmacology; 2020 Feb; 163():107808. PubMed ID: 31706993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders.
    Baswan SM; Klosner AE; Glynn K; Rajgopal A; Malik K; Yim S; Stern N
    Clin Cosmet Investig Dermatol; 2020; 13():927-942. PubMed ID: 33335413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Endocannabinoid System and Cannabidiol's Promise for the Treatment of Substance Use Disorder.
    Chye Y; Christensen E; Solowij N; Yücel M
    Front Psychiatry; 2019; 10():63. PubMed ID: 30837904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study.
    Chester LA; Englund A; Chesney E; Oliver D; Wilson J; Sovi S; Dickens AM; Oresic M; Linderman T; Hodsoll J; Minichino A; Strang J; Murray RM; Freeman TP; McGuire P
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):188-198. PubMed ID: 36493386
    [No Abstract]   [Full Text] [Related]  

  • 37. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
    Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
    PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective Effects of Cannabidiol but Not Δ
    Landucci E; Mazzantini C; Lana D; Davolio PL; Giovannini MG; Pellegrini-Giampietro DE
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575932
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders.
    García-Gutiérrez MS; Navarrete F; Gasparyan A; Austrich-Olivares A; Sala F; Manzanares J
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33228239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interacting binding insights and conformational consequences of the differential activity of cannabidiol with two endocannabinoid-activated G-protein-coupled receptors.
    Dávila EM; Patricio F; Rebolledo-Bustillo M; Garcia-Gomez D; Hernandez JCG; Sanchez-Gaytan BL; Limón ID; Perez-Aguilar JM
    Front Pharmacol; 2022; 13():945935. PubMed ID: 36016551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.